What are Adaptive Biotechnologies's Business Segments?
Adaptive Biotechnologies Corporation is a biotechnology company that specializes in developing and providing immunosequencing products and services. They have developed a platform called immune medicine that helps to decode the human immune system that in turn will improve the diagnosis and treatment of various diseases.
Segments:
Adaptive Biotechnologies Corporation mainly focuses on developing and providing services that decode the immune system in the following areas:
1. Clinical Diagnostics: Adaptive Biotechnologies Corporation provides services to help diagnose and monitor various diseases such as cancer, infectious diseases, and autoimmune disorders. They offer clinical-grade tools such as immunoSEQ Dx, a clinical immunosequencing assay diagnostic test that is FDA-cleared and helps in disease diagnosis.
2. Life Sciences Research: Adaptive Biotechnologies Corporation provides research and development services to academic and commercial organizations to better understand the immune system. They offer research-grade tools and services such as the immunoSEQ Technology, a research-use-only assay that allows investigators to measure the diversity and frequency of the T-cell and B-cell receptor.
Products:
Adaptive Biotechnologies Corporation has developed a range of products that use the immune sequencing technologies to aid in disease diagnosis and treatment. Some of the products are:
1. immunoSEQ Dx: This is a clinical immunosequencing assay diagnostic test that is FDA-cleared for use in diagnosing and monitoring various diseases such as cancer, infectious diseases, and autoimmune disorders.
2. immunoSEQ Research Products: These are research-use-only assays that measure the diversity and frequency of the T-cell and B-cell receptors. This helps in better understanding the immune system and developing targeted therapies.
3. clonoSEQ: This is a minimal residual disease (MRD) detection assay that helps in the monitoring and management of blood cancers such as leukemia and lymphoma.
Services:
Adaptive Biotechnologies Corporation offers various services related to immunosequencing technology that aid in disease diagnosis and treatment. Some of the services are:
1. Clinical Testing Services: Adaptive Biotechnologies Corporation provides clinical-grade services such as immunoSEQ Dx, immunoSEQ Monitor, and clonoSEQ that aid in the diagnosis and monitoring of various diseases such as cancer, infectious diseases, and autoimmune disorders.
2. Research and Development Services: Adaptive Biotechnologies Corporation provides services related to research and development of immunosequencing technology to academic and commercial organizations. These services include the immunoSEQ Technology that measures the diversity and frequency of the T-cell and B-cell receptors.
3. Sample Preparation and Sequencing Services: Adaptive Biotechnologies Corporation provides sample preparation and sequencing services that help researchers gather, prepare, and analyze samples needed for immunosequencing technology.
In conclusion, Adaptive Biotechnologies Corporation offers a wide range of services and products that help researchers and clinicians better understand, diagnose, and treat various diseases. Their immunosequencing platform, immune medicine, has the potential to revolutionize disease diagnosis and treatment.
|